
Haemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) can rapidly progress, leading to organ failure and death. A task force of global experts developed evidence-based points to assist clinicians in early diagnosis, treatment, and monitoring. The guidelines emphasize prompt syndrome recognition, systematic evaluation of underlying causes, early intervention to target hyperinflammation, and multidisciplinary support.
Like
Save
Share